• Safer estrogen metabolism
• Risk reduction for women's cancers
• Respiratory Papillomatosis (RP)
Serving Size: 1 Capsule
Indole-3-Carbinol (I-3-C) … 200 mg
Non-medicinalingredients: microcrystalline cellulose. Capsule: hypromellose.
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish, shellfish, or any animal byproduct.
Source: Synthesis from indole
What Is It?
Indole-3-carbinol (I-3-C) is a phytonutrient found in Brassica vegetables, like broccoli and cabbage. I-3-C is one of the key cancer-fighting ingredients in these foods. Though converted to DIM (3,3'-diindolylmethane) in the body, many studies have had phenomenal success using I-3-C as a supplement.
What Does It Do?
Primary Uses: Studies have revealed that by shifting the balance of metabolic enzymes that process estrogens, I-3-C reduces the formation of "bad" estrogens and increases the formation of "good" estrogens. Human studies in women taking I-3-C have shown a favourable shift in estrogen metabolism, and I-3-C has been shown to be protective against estrogen dominance in women.
Who Should Take It?
Women who are concerned with safer estrogen metabolism, who have a family history or increased risk of estrogen-dependent cancers, or have a higher ratio of bad to good estrogens. I-3-C may also be a beneficial supplement for those who want to reap some of the benefits of cruciferous vegetables like broccoli but have difficulty eating it raw.
Take 1 capsule twice a day with or without food for up to 12 weeks, or as directed by a qualified health care practitioner.
Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM. “
Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.”
Gynecol Oncol. 2000 Aug; 78(2): 123-9.
Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. “
2-hydroxyestrone: the ‘good' estrogen.”
J Endocrinol. 1996 Sep; 150 Suppl: S259-65.
Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GY, Osborne MP. “
Long-term responses of women to indole-3-carbinol or a high fiber diet.”
Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov; 3(7): 591-5.
Chen I, McDougal A, Wang F, Safe S. “
Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.”
Carcinogenesis. 1998 Sep; 19(9): 1631-9.
Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. “
Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.”
Biochem Pharmacol. 1993 Mar 9; 45(5): 1129-36.
Michnovicz JJ. “
Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol.”
Int J Obes Relat Metab Disord. 1998 Mar; 22(3): 227-9.
Michnovicz JJ, Adlercreutz H, Bradlow HL. “
Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans.”
J Natl Cancer Inst. 1997 May 21; 89(10): 718-23.
Michnovicz JJ, Bradlow HL. “
Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.”
Nutr Cancer. 1991; 16(1): 59-66.
Riby JE, Chang GH, Firestone GL, Bjeldanes LF. “
Ligand-independent activation of estrogen receptor function by 3, 3\'-diindolylmethane in human breast cancer cells.”
Biochem Pharmacol. 2000 Jul 15; 60(2): 167-77.
Sanderson JT, Slobbe L, Lansbergen GW, Safe S, van den Berg M. “
2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially inducecytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells.”
Toxicol Sci. 2001 May; 61(1): 40-8.
Taioli E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ. “
Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.”
Cancer Detect Prev. 1999; 23(3): 232-7.
Wong GY, Bradlow L, Sepkovic D, Mehl S, Mailman J, Osborne MP. “
Dose-ranging study of indole-3-carbinol for breast cancer prevention.”
J Cell Biochem Suppl. 1997; 28-29:111-6.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.